Treatment for SSRI-Induced Dry Eyes

First-Line Treatment Algorithm

The American Academy of Ophthalmology recommends beginning with preservative-free methylcellulose or hyaluronate-based artificial tears at least twice daily, increasing frequency based on symptom severity up to hourly application 1, 2
The American Academy of Ophthalmology suggests using preservative-free formulations when applying more than 4 times daily to avoid ocular surface toxicity 1, 3
Applying liquid drops during daytime hours, gels for longer-lasting daytime effect, and ointments before bedtime for overnight protection is recommended by the American Academy of Ophthalmology 1, 2
Morning lid hygiene after overnight ointment use is necessary to prevent blepharitis, as recommended by the American College of Rheumatology 4, 5

The American Academy of Ophthalmology recommends eliminating all cigarette smoke exposure, as smoking adversely affects the tear film lipid layer 1, 2
Humidifying ambient air and using side shields on spectacles to minimize air draft exposure is suggested by the American Academy of Ophthalmology 1, 2
Lowering computer screens below eye level and scheduling 20-minute breaks to increase full blinking during screen time is recommended by the American Academy of Ophthalmology 1, 2

The American Academy of Ophthalmology recommends adding cyclosporine 0.05% ophthalmic emulsion one drop in each eye twice daily, approximately 12 hours apart, with demonstrated success rates of 74% in mild, 72% in moderate, and 67% in severe dry eye 2
Topical corticosteroids should be used for a maximum of 2-4 weeks only to decrease acute ocular irritation and corneal staining, as recommended by the American College of Rheumatology 4, 5, 1

The American Academy of Ophthalmology suggests punctal plugs or punctal cautery for tear retention after optimizing topical therapy 1, 2
Autologous serum eye drops can improve ocular irritation symptoms and corneal/conjunctival staining, as recommended by the American Academy of Ophthalmology 1, 2

The American Academy of Ophthalmology warns that preserved artificial tears used more than 4 times daily can cause ocular surface toxicity, and recommends switching to preservative-free formulations at this frequency 1, 3
Continuing topical corticosteroids beyond 4 weeks can risk serious complications, such as infections, increased intraocular pressure, and cataract development, as warned by the American College of Rheumatology 4, 5

Moderate or severe eye pain unresponsive to initial therapy requires ophthalmology referral, as recommended by the American Academy of Ophthalmology 3
Lack of response after 2-4 weeks of optimized treatment, corneal infiltration, ulceration, or any vision loss also require ophthalmology referral, as recommended by the American Academy of Ophthalmology 3